17-42799074-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_173478.3(CNTD1):c.7G>A(p.Gly3Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00134 in 1,613,756 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00079 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 4 hom. )
Consequence
CNTD1
NM_173478.3 missense
NM_173478.3 missense
Scores
16
Clinical Significance
Conservation
PhyloP100: -0.175
Genes affected
CNTD1 (HGNC:26847): (cyclin N-terminal domain containing 1) Predicted to be involved in reciprocal meiotic recombination. Predicted to act upstream of or within spermatogenesis. Predicted to be active in site of double-strand break. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010126799).
BP6
Variant 17-42799074-G-A is Benign according to our data. Variant chr17-42799074-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2389299.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNTD1 | NM_173478.3 | c.7G>A | p.Gly3Arg | missense_variant | 1/7 | ENST00000588408.6 | NP_775749.2 | |
CNTD1 | NM_001330222.2 | c.-81+56G>A | intron_variant | NP_001317151.1 | ||||
CNTD1 | XM_024450569.2 | c.13+244G>A | intron_variant | XP_024306337.1 | ||||
CNTD1 | XM_011524311.3 | c.-5+244G>A | intron_variant | XP_011522613.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNTD1 | ENST00000588408.6 | c.7G>A | p.Gly3Arg | missense_variant | 1/7 | 1 | NM_173478.3 | ENSP00000465204.1 |
Frequencies
GnomAD3 genomes AF: 0.000789 AC: 120AN: 152184Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
120
AN:
152184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000722 AC: 181AN: 250648Hom.: 0 AF XY: 0.000752 AC XY: 102AN XY: 135584
GnomAD3 exomes
AF:
AC:
181
AN:
250648
Hom.:
AF XY:
AC XY:
102
AN XY:
135584
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00140 AC: 2044AN: 1461572Hom.: 4 Cov.: 31 AF XY: 0.00140 AC XY: 1018AN XY: 727118
GnomAD4 exome
AF:
AC:
2044
AN:
1461572
Hom.:
Cov.:
31
AF XY:
AC XY:
1018
AN XY:
727118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000789 AC: 120AN: 152184Hom.: 0 Cov.: 31 AF XY: 0.000713 AC XY: 53AN XY: 74340
GnomAD4 genome
AF:
AC:
120
AN:
152184
Hom.:
Cov.:
31
AF XY:
AC XY:
53
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
8
ExAC
AF:
AC:
83
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of solvent accessibility (P = 0.0674);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at